vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and Piedmont Realty Trust, Inc. (PDM). Click either name above to swap in a different company.
Piedmont Realty Trust, Inc. is the larger business by last-quarter revenue ($143.3M vs $75.5M, roughly 1.9× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 0.4%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 0.0%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Piedmont Realty Trust, Inc. is a publicly traded real estate investment trust (REIT) that owns, operates, and invests in high-quality office properties primarily located in high-growth metropolitan areas across the United States. It serves corporate tenants across multiple industry sectors including technology, professional services, and healthcare, and pursues stable long-term returns for stakeholders via strategic property management and portfolio optimization.
PBYI vs PDM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $143.3M |
| Net Profit | — | $-45.0M |
| Gross Margin | 69.3% | — |
| Operating Margin | 22.7% | — |
| Net Margin | — | -31.4% |
| Revenue YoY | 27.7% | 0.4% |
| Net Profit YoY | — | -27.9% |
| EPS (diluted) | $0.26 | $-0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $143.3M | ||
| Q4 25 | $75.5M | $142.9M | ||
| Q3 25 | $54.5M | $139.2M | ||
| Q2 25 | $52.4M | $140.3M | ||
| Q1 25 | $46.0M | $142.7M | ||
| Q4 24 | $59.1M | $143.2M | ||
| Q3 24 | $80.5M | $139.3M | ||
| Q2 24 | $47.1M | $143.3M |
| Q1 26 | — | $-45.0M | ||
| Q4 25 | — | $-43.2M | ||
| Q3 25 | $8.8M | $-13.5M | ||
| Q2 25 | $5.9M | $-16.8M | ||
| Q1 25 | $3.0M | $-10.1M | ||
| Q4 24 | — | $-30.0M | ||
| Q3 24 | $20.3M | $-11.5M | ||
| Q2 24 | $-4.5M | $-9.8M |
| Q1 26 | — | — | ||
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | 22.7% | — | ||
| Q3 25 | 17.6% | — | ||
| Q2 25 | 12.7% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 22.6% | — | ||
| Q3 24 | 27.4% | — | ||
| Q2 24 | -4.6% | — |
| Q1 26 | — | -31.4% | ||
| Q4 25 | — | -30.3% | ||
| Q3 25 | 16.2% | -9.7% | ||
| Q2 25 | 11.2% | -12.0% | ||
| Q1 25 | 6.5% | -7.1% | ||
| Q4 24 | — | -20.9% | ||
| Q3 24 | 25.2% | -8.3% | ||
| Q2 24 | -9.6% | -6.8% |
| Q1 26 | — | $-0.10 | ||
| Q4 25 | $0.26 | $-0.34 | ||
| Q3 25 | $0.17 | $-0.11 | ||
| Q2 25 | $0.12 | $-0.14 | ||
| Q1 25 | $0.06 | $-0.08 | ||
| Q4 24 | $0.40 | $-0.25 | ||
| Q3 24 | $0.41 | $-0.09 | ||
| Q2 24 | $-0.09 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $2.3M |
| Total DebtLower is stronger | $22.7M | — |
| Stockholders' EquityBook value | $130.3M | $1.5B |
| Total Assets | $216.3M | $4.0B |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.3M | ||
| Q4 25 | $97.5M | $731.0K | ||
| Q3 25 | $94.4M | $3.0M | ||
| Q2 25 | $96.0M | $3.3M | ||
| Q1 25 | $93.2M | $2.9M | ||
| Q4 24 | $101.0M | $109.6M | ||
| Q3 24 | $96.7M | $133.6M | ||
| Q2 24 | $96.8M | $138.5M |
| Q1 26 | — | — | ||
| Q4 25 | $22.7M | $2.2B | ||
| Q3 25 | $34.0M | $2.2B | ||
| Q2 25 | $45.3M | $2.2B | ||
| Q1 25 | $56.7M | $2.2B | ||
| Q4 24 | $68.0M | $2.2B | ||
| Q3 24 | $79.3M | $2.2B | ||
| Q2 24 | $90.7M | $2.2B |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $130.3M | $1.5B | ||
| Q3 25 | $115.3M | $1.5B | ||
| Q2 25 | $104.7M | $1.5B | ||
| Q1 25 | $97.1M | $1.6B | ||
| Q4 24 | $92.1M | $1.6B | ||
| Q3 24 | $71.1M | $1.6B | ||
| Q2 24 | $48.5M | $1.7B |
| Q1 26 | — | $4.0B | ||
| Q4 25 | $216.3M | $4.0B | ||
| Q3 25 | $202.9M | $4.0B | ||
| Q2 25 | $194.9M | $4.0B | ||
| Q1 25 | $196.2M | $4.0B | ||
| Q4 24 | $213.3M | $4.1B | ||
| Q3 24 | $220.7M | $4.1B | ||
| Q2 24 | $205.0M | $4.2B |
| Q1 26 | — | — | ||
| Q4 25 | 0.17× | 1.49× | ||
| Q3 25 | 0.30× | 1.43× | ||
| Q2 25 | 0.43× | 1.41× | ||
| Q1 25 | 0.58× | 1.40× | ||
| Q4 24 | 0.74× | 1.40× | ||
| Q3 24 | 1.12× | 1.36× | ||
| Q2 24 | 1.87× | 1.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | — |
| Free Cash FlowOCF − Capex | $14.4M | — |
| FCF MarginFCF / Revenue | 19.1% | — |
| Capex IntensityCapex / Revenue | 0.0% | 110.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | $140.6M | ||
| Q3 25 | $9.7M | $35.8M | ||
| Q2 25 | $14.1M | $50.1M | ||
| Q1 25 | $3.6M | $3.7M | ||
| Q4 24 | $15.6M | $198.1M | ||
| Q3 24 | $11.0M | $42.9M | ||
| Q2 24 | $1.0M | $66.8M |
| Q1 26 | — | — | ||
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — |
| Q1 26 | — | 110.3% | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
